...
首页> 外文期刊>BJU international >Overexpression of cyclooxygenase-2 in high-grade human transitional cell carcinoma of the upper urinary tract.
【24h】

Overexpression of cyclooxygenase-2 in high-grade human transitional cell carcinoma of the upper urinary tract.

机译:环氧合酶-2在高级别人类上尿路移行细胞癌中的过表达。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: To examine cyclooxygenase (COX)-2 expression (a key enzyme in the synthesis of prostaglandins, and involved in carcinogenesis of human epithelial tumours) in human transitional cell carcinomas (TCCs) of the renal pelvis and ureter, and to determine whether COX-2 expression correlates with the clinicopathological characteristics of the disease. MATERIALS AND METHODS: Specimens from 144 patients with TCC of the upper urinary tract who had undergone nephroureterectomy were analysed immunohistochemically, and 23 were also analysed by immunoblotting. RESULTS: Immunoblot analysis showed COX-2 immunoreactivity in 17 (74%) of 23 tumours, but not in normal transitional epithelium. COX-2 was localized to the cytoplasm of cancer cells and expressed in 108 (75%) of 144 tumours, as assessed by immunohistochemical analysis. COX-2 expression correlated with tumour grade (P < 0.008), being detected in one of nine grade 1, 77 (79%) of 97 grade 2 and 30 (79%) of 38 grade 3 tumours. Other variables including tumour stage were not associated with COX-2 expression. CONCLUSIONS: We show for the first time that COX-2 is frequently expressed in TCC of the upper urinary tract and is associated with the degree of tumour cell differentiation, indicating that COX-2 may be involved in TCC carcinogenesis at an early and/or late stage, and could be a useful target for chemoprevention of this type of cancer.
机译:目的:研究人肾盂和输尿管移行细胞癌(TCC)中环氧合酶(COX)-2的表达(前列腺素合成中的关键酶,参与人上皮肿瘤的致癌作用),并进行研究。 -2表达与疾病的临床病理特征相关。材料与方法:免疫组织化学分析了144例接受了肾结直肠癌切除术的上尿路TCC患者的标本,并对23例患者进行了免疫印迹分析。结果:免疫印迹分析显示,在23种肿瘤中有17种(74%)具有COX-2免疫反应性,而在正常的过渡上皮中则没有。通过免疫组织化学分析评估,COX-2定位于癌细胞的细胞质,并在144个肿瘤中的108个(75%)中表达。 COX-2表达与肿瘤等级相关(P <0.008),在9个1级,2个97级(77%)和38个3级(30%)肿瘤之一中被检测到。其他变量包括肿瘤分期与COX-2表达无关。结论:我们首次显示COX-2在上尿路TCC中频繁表达,并与肿瘤细胞分化程度有关,这表明COX-2可能在早期和/或早期参与TCC癌变晚期,可能是化学预防这类癌症的有用靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号